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Alternative splicing is a well-recognized mechanism of accelerated genome evolution. We have studied single-nucleotide polymor-
phisms and human-chimpanzee divergence in the exons of 6672 alternatively spliced human genes, with the aim of understanding
the forces driving the evolution of alternatively spliced sequences. Here, we show that alternatively spliced exons and exon fragments
(alternative exons) from minor isoforms experience lower selective pressure at the amino acid level, accompanied by selection against
synonymous sequence variation. The results of the McDonald-Kreitman test suggest that alternatively spliced exons, unlike exons con-
stitutively included in the mRNA, are also subject to positive selection, with up to 27% of amino acids ﬁxed by positive selection.Alternative splicing (AS) of genes is the processing of an
RNA transcript into various mRNA molecules (and hence
proteins) by the inclusion of some exons and the exclusion
of others. It is one of the major sources of eukaryotic pro-
teome complexity,1,2 with the estimates of the fraction of
alternatively spliced genes in the human genome gradually
increasing over time, from 35%3 up to 70%–80%.4,5 Alter-
native splicing also seems to be an important mechanism
of accelerated genome evolution, associated with relaxa-
tion of the selection pressure against certain types of evolu-
tionary events on both the level of the exon-intron
structure and the level of individual nucleotides.2,6,7 In par-
ticular, AS signiﬁcantly relaxes the selection pressure
against amino acid substitutions,8 with strongermanifesta-
tion in the C-terminal alternatives.9 Simultaneous increase
in the conservation of synonymous sites is also observed.8
Species-speciﬁc AS is also associated with lower amino acid
conservation in constitutive exons,10 with evolutionarily
young exons evolving at a higher rate.11 However, none
of the listed studies attempted to distinguish between
positive selection and relaxed negative selection.
A common measure of the degree of evolutionary con-
straint on a sequence is the ratio Ka/Ks of nonsynonymous
substitutions per nonsynonymous site (Ka) to synony-
mous substitutions per synonymous site (Ks), with higher
values of the ratio indicating weaker negative selection act-
ing on a sequence.9 In the past years, several approaches
have been applied to the detection of positive selection
in the human genome,12,13 but not all of them can be
used in the case of closely intermixed genomic regions,
characteristic of genomic AS. However, the availability of
the SNP data makes it possible to apply a more-advanced
analysis via the McDonald-Kreitman test,14 which enables
the detection of positive Darwinian selection in the pres-
ence of negative selection.15,16 Here, we investigate the dif-94 The American Journal of Human Genetics 83, 94–98, July 2008ferences between the rates of synonymous and nonsynon-
ymous polymorphism and of human-chimpanzee
variation in alternative and constitutive regions of human
genes. The novelty of the study is in the simultaneous
analysis of polymorphism and divergence data in the cod-
ing regions of two types, revealing not only the relaxation
of negative selection pressure associated with AS8,9,11 but
also the presence of a signiﬁcant difference in positive-se-
lection strength between the alternative and the constitu-
tive regions.
The splicing alternatives were derived from EDAS,17 a
database containing genomic, protein, mRNA, and EST
sequences, and then processed by IsoformCounter.18 The
latter is a conservative algorithm for the construction of
a representative and nonredundant set of protein isoforms
compatible with AS data for a gene (see ref. 18 for isoform-
quality-validation details). A generated isoform is accom-
panied by the start and stop codons, the reading frame,
and the effective number of sequences representing each
coding region, thus enabling markup of a gene into alter-
native and constitutive fragments with known reading
frames, as shown in Figure S1. Exons not completely
aligned to the chimpanzee genome, genes without poly-
morphism data, and sequence variations in the ﬁrst and
last codons of a fragment were not considered. Exons
were deﬁned as conserved if they had donor and acceptor
sites conserved in at least one of the orthologous mouse
and dog genes and as nonconserved if either the exon or
the entire gene was not conserved in both dog and mouse.
To avoid contamination by misspliced or otherwise non-
functional isoforms, we considered only conserved exons
or nonconserved but still functional exons from genes
for which at least 60 EST sequences were known. This pro-
cedure generated 52,151 constitutive and 14,196 alterna-
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and Lee,8 we deﬁne the exon-inclusion level A, 0 < A% 1,
as the total number of all protein, mRNA, and EST se-
quences that cover the corresponding exon and include
it completely divided by the total number of sequences
covering the exon. All regions were then divided into three
major classes: minor (0 < A < 2/3; N ¼ 4397 fragments),
major (2/3 % A < 1; N ¼ 9799), and constitutive (A ¼ 1;
N ¼ 52,151).
Furthermore, 6465 SNPs from build 125 of the dbSNP
database19 and 50,649 human-chimpanzee substitutions
derived from the whole-genome alignments20 were map-
ped to the genes. In order to overcome the biased nature
of the polymorphism data submitted to dbSNP, we consid-
ered only SNPs marked as ‘‘validated’’ and obtained
by the following methods:21 EGP_SNPS (NIEHS/Seattle
data), CSHL-HAPMAP, TSC-CSHL, SC, SC_JCM, SC_SNP,
BCM_SSAHASNP, SSAHASNP, WI_SSAHASNP, or
WUGSC_SSAHASNP. SNP frequencies were derived from
genotype data in dbSNP build 128. This forms the basic
set of SNPs. We also considered separately a subset of
4977 SNPs from the basic set observed in either JamesWat-
son’s Personal Genome Sequence22 or Celera’s Individual A
(dbSNP methodWGSA-200403). Also, 6499 SNPs from the
Applera data16 mapped to the AS genes were used as a sep-
arate test set.
The Ka/Ks ratios for SNPs and divergence (Figure 1) are
very close for constitutive and major alternative regions
but differ more than two-fold from those for functional
minor alternative regions, conﬁrming that lower negative
selection against amino acid substitutions is especially
characteristic of these fragments. These observations hold
when only neutral SNPs are considered or when conserved
and nonconserved exons are considered separately (the
complete data from Figure 1 and Table 1 are given in Table
S1). Table 1 also contains the results of the McDonald-
Kreitman test, in which the numbers of synonymous poly-
morphisms (Ps) and substitutions (Ds) and the numbers of
nonsynonymous polymorphisms (Pa) and substitutions
(Da) are compared in a contingency table. A statistically
signiﬁcant excess of nonsynonymous substitutions rela-
tive to polymorphisms (Da/Ds > Pa/Ps) implies positive se-
lection that provides ﬁxation of advantageous mutations.
The fraction a of ﬁxed amino acid substitutions driven
by positive selection is then estimated as a ¼ 1(Pa/Ps)/
(Da/Ds).23 This value equals 0.27 for the minor alterna-
tives, suggesting that they experience positive selection.
For major alternatives and constitutive exons, a < 0 indi-
cates purifying selection (Table 1A). The Fisher test value
F given in the last column of Table 1 and Table S1 reﬂects
the probability that the difference between Da/Ds and
Pa/Ps is random. In the basic set, it equals 0.001 for minor
alternatives. Taking into consideration that synonymous
and nonsynonymous SNPs are not independent in indi-
vidual genes, we performed 10,000 permutation tests. In
each test, types of 52,151 constant and 4397 minor alter-
natively spliced exons from the basic set were randomly
permuted between the two categories of exons, and thecorresponding values were calculated for each category.
The observed value a ¼ 0.27 falls within the 0.0015 quan-
tile of thus generated random distribution of a. The result
of the permutation test does not provide direct evidence
for positive selection, but it gives an independent support
to the statistical signiﬁcance of theDa/Ds excess over Pa/Ps
in the minor alternative exons.
We have repeated the analysis on SNPs from the basic set
observed in two individual genomes (Table S1F). The
values of a for constitutive, major, and minor exons were
–0.05, –0.02, and 0.23, respectively, conﬁrming the basic
result albeit with a lower statistical signiﬁcance due to
the smaller number of SNPs in the subset (Fisher test value
0.02 for the minor alternatives). The results of the McDo-
nald-Kreitman test on SNPs from the Applera dataset map-
ped to the genes with AS are given in Table S1G. Formally,
a equals 0.24 for minor isoforms and is in good agreement
with previous results. However, the statistical signiﬁcance
of this observation is low (the Fisher test value is 0.13),
due to the small number of SNPs in the minor alternative
exons. The primer-selection procedure described in ref. 16
yielded a low fraction of SNPs from this dataset mapping
to gene introns (< 40%). This suggests that the coverage
provided by this set is skewed toward constitutive exons.
Positive selection in the minor alternatives is still ob-
served when the exons are split into conserved (a ¼ 0.35,
Table 1B), and nonconserved (a ¼ 0.23, Table 1C) cate-
gories. On the other hand, the a values in the constitutive
and major alternative exons differ between these two
groups, with negative selection (a < 0) characteristic for
the conserved exons and positive selection (a > 0) domi-
nating in the nonconserved ones. These data also conﬁrm
the similar behavior of the constitutive and major alterna-
tive exons.24 Thus, all types of nonconserved exons seem
to experience positive selection.
The above analysis could be compromised by the fact
that the McDonald-Kreitman test relies on the assump-
tion that the polymorphism accounted for is neutral. To
eliminate potentially mildly deleterious SNPs that might
have accumulated in the human population, e.g., as a re-
sult of rapid population expansion, we have repeated the
test with SNPs for which the frequency of the derived
(new) allele is known and not less than 5% (Table 1D
and Table S1D) or 10% (Table S1E). With these presum-
ably neutral SNPs, for minor alternatives the a fractions
of substitutions ﬁxed by positive selection are then esti-
mated as 0.27 and 0.29, respectively, with Fisher’s test
value ~0.01. This moderate increase conforms with the
expectation that weakly relaxed selection on mildly dele-
terious minor-alternative SNPs would inﬂate the Pa num-
ber and therefore decrease the a value, thus making our
basic test with all SNPs rather a conservative estimate.
Positive selection also appears in the major regions (a ¼
0.19 and 0.22 for the 5% and 10% SNPs, respectively),
suggesting that in the total sample weaker positive
selection in the major exons is masked by the presence
of nonneutral SNPs.The American Journal of Human Genetics 83, 94–98, July 2008 95
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are slightly lower in minor AS exons (Table S1A). This ob-
servation can be explained by RNA-level selection acting
on synonymous sites of alternatively spliced exons in or-
der to maintain the splicing-regulation motifs, ESEs (ex-
onic splicing enhancers) in particular.8,25–28 In the case
of presumably neutral polymorphisms (Table S1D), the re-
duction of Ks values between constitutive and minor
exons is close for polymorphism and divergence: 22%
and 25%, respectively. The Pa/Ps and Da/Ds ratios used
in the McDonald-Kreitman test are therefore almost
equally affected by this fact, and the observed positive se-
lection is indeed driven by nonsynonymous variation.
Figure 1. Substitution Rates in Constitutive, Major and
Minor Alternatively Spliced Exons of Human Genes
(A) Nonsynonymous (Ka) and synonymous (Ks) substitution
rates for SNPs (SNP) and human-chimpanzee divergence substi-
tutions (Div). The Ka values are lower and the Ks values are
higher in the minor exons.
(B) Same as (A), but only neutral SNPs (with frequency > 5%)
are considered.
(C) The Ka/Ks ratios in the minor exons are consistently higher
for SNPs and divergence in the total sample and when only
neutral SNPs are considered.
However, when all SNPs are considered (Table S1A),
the Ks value for polymorphisms in minor exons is
only 7% lower than that for constitutive exons, suggest-
ing that a fraction of synonymous SNPs might be
mildly deleterious for the former.
The excess of nonsynonymous SNPs and ﬁxed substi-
tutions in the minor alternatively spliced fragments of
human genes suggests that they are under lower purify-
ing-selection pressure. As shown by the results of the
McDonald-Kreitman test, they also experience positive
selection, observed both in conserved and noncon-
served exons. With some sacriﬁce of statistical signiﬁ-
cance, this result is also conﬁrmed by two more-conser-
vative subsets with high-frequency SNPs, providing the
strict case of presumably neutral variation. These tests,
along with those restricted to SNPs from two personal
genomes providing uniform genome coverage, seem
to be a reasonable compromise in the present-day ab-
sence of an ‘‘ideal’’ perfectly ascertained set of SNPs
that is sufﬁciently large to represent minor protein iso-
forms. One should be aware, however, that the nonsys-
tematic nature of the data may be a potential source of
artifactual effects in polymoprhism-related studies.
Positive selection could not be observed in earlier
studies relying on comparisons of Ka/Ks values in the al-
ternative and constitutive regions of pairwise-aligned
mammalian genes,9 because the latter technique does
not allow one to distinguish between positive selection
and relaxed negative selection. The advantage of the
McDonald-Kreitman test is that it detects the fraction
of between-species amino acid diversity that cannot
be explained by neutral variation.23 In our case, the in-
crease of nonsynonymous diversity in minor isoforms is
greater than that expected due to relaxation of negative se-
lection estimated from the polymorphism levels and can
naturally be interpreted as a trace of positive selection.
As more mammalian genomes are being sequenced, an
opportunity to use the methods for estimating positive
selection based on representative multiple alignments
will appear as a sufﬁcient number of reliable genomic
sequences become available.29
Unexpectedly, the fraction of amino acid substitutions
ﬁxed by positive selection in the conserved minor alterna-
tive exons is higher than that in nonconserved exons96 The American Journal of Human Genetics 83, 94–98, July 2008
(a ¼ 0.35 versus a ¼ 0.23). This fact could be explained by
contamination of the minor-isoform sample by aberrantly
spliced, nonfunctional exons, blurring the evidence for
selection. Indeed, nonconserved minor alternative exons
are always suspicious,30 and thus this result should be
re-examined as more data become available. It should be
noted, however, that the fact that positive selection is ob-
served in both conserved and nonconserved minor exons
provides independent support for the main ﬁnding of this
study. This is consistent with a recent theory, according to
which new exons emerge by ﬁxation of aberrant splicing
events, with subsequent upregulation of functionally
useful variants. Indeed, because minor alternative exons,
unlike constitutive and major alternative ones, seem to be
relatively young,11,24,29 they are a natural substrate for
positive selection.
Supplemental Data
One ﬁgure and one table are available with this paper online at
http://www.ajhg.org/.
Table 1. SNP and Divergence Density Values and the
McDonald-Kreitman Test
Exon Type
Number
of Exons
Ka/Ks
(SNP)
Ka/Ks
(Div) a
Fisher Test
Significance
All Exonsa
Constitutive 52151 0.26 0.25 0.04 0.118
Major 9799 0.26 0.26 0.02 0.442
Minor 4397 0.55 0.76 0.27 0.001
Conserved Exonsb
Constitutive 42590 0.25 0.23 0.09 0.008
Major 7218 0.26 0.23 0.16 0.069
Minor 2023 0.40 0.62 0.35 0.009
Nonconserved Exonsc
Constitutive 9561 0.29 0.32 0.09 0.056
Major 2581 0.27 0.34 0.21 0.052
Minor 2374 0.66 0.85 0.23 0.026
All Exons, SNPs with Derived Allele FrequencyR 5%d
Constitutive 30060 0.25 0.25 0.04 0.149
Major 4801 0.23 0.29 0.19 0.015
Minor 2026 0.54 0.74 0.27 0.012
The table contains the ratio values Ka/Ks of nonsynonymous substitutions
per nonsynonymous site (Ka) to synonymous substitutions per synonymous
site (Ks) for three types of gene regions. Ka and Ks denote both polymor-
phism densities and divergence, with discriminating labels ‘‘SNP’’ and
‘‘Div,’’ respectively. The last column shows the significance computed by
the Fisher test applied to the four numbers organized in a 2 3 2 contin-
gency table.
a All exons.
b Conserved exons.
c Nonconserved exons from genes covered byR 60 ESTs.
d Genes with at least one SNP with known frequency, only neutral SNPs
(both validated and nonvalidated) with the frequency of the derived
(new) allele R 5%.Acknowledgments
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